DexCom Gets FDA Approval On Android App For Blood Glucose Monitoring

San Diego-based medical device maker DexCom announced this morning that the FDA has approved its G5 Mobile App, the company's system for monitoring a users' blood glucose level, which runs on Android phones. According to DexCom, the Android mobile app will be avaliable beginning this month, allowing people with diabetes to view and monitor their glucose levels on their mobile devices. DexCom already had approval on the iOS version of its app since 2015. Both apps work with Dexcom's G5 Mobile CGM System devices.